{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:58:55Z","timestamp":1793782735220,"version":"4.6.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Risk prediction for subsequent cardiovascular events remains an unmet clinical issue in patients with coronary artery disease. We aimed to investigate prognostic metabolic biomarkers by considering both shared and distinct metabolic disturbance associated with the composite and individual cardiovascular events. Here, we conducted an untargeted metabolomics analysis for 333 incident cardiovascular events and 333 matched controls. The cardiovascular events were designated as cardiovascular death, myocardial infarction\/stroke and heart failure. A total of 23 shared differential metabolites were associated with the composite of cardiovascular events. The majority were middle and long chain acylcarnitines. Distinct metabolic patterns for individual events were revealed, and glycerophospholipids alteration was specific to heart failure. Notably, the addition of metabolites to clinical markers significantly improved heart failure risk prediction. This study highlights the potential significance of plasma metabolites on tailed risk assessment of cardiovascular events, and strengthens the understanding of the heterogenic mechanisms across different events.<\/jats:p>","DOI":"10.1038\/s41467-024-50125-2","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T20:21:59Z","timestamp":1720470119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Plasma metabolomics reveals the shared and distinct metabolic disturbances associated with cardiovascular events in coronary artery disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Jiali","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5701-3609","authenticated-orcid":false,"given":"Yuping","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0072-3703","authenticated-orcid":false,"given":"Jiaojiao","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4670-3727","authenticated-orcid":false,"given":"Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3684-4363","authenticated-orcid":false,"given":"Shuo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianzhang","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fandong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Jiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1048-4443","authenticated-orcid":false,"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2934-4582","authenticated-orcid":false,"given":"Jiali","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9501-2546","authenticated-orcid":false,"given":"Yuguo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,8]]},"reference":[{"key":"50125_CR1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD Diseases","year":"2020","unstructured":"Diseases, G. B. D. & Injuries, C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396, 1204\u20131222 (2020).","journal-title":"Lancet"},{"key":"50125_CR2","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.4244\/EIJ-D-21-00192","volume":"17","author":"T Asano","year":"2022","unstructured":"Asano, T. et al. Temporal trends in clinical outcomes after percutaneous coronary intervention: a systematic review of 66,327 patients from 25 all-comers trials. EuroIntervention 17, 1318\u20131329 (2022).","journal-title":"EuroIntervention"},{"key":"50125_CR3","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jacc.2019.06.030","volume":"74","author":"K Caidahl","year":"2019","unstructured":"Caidahl, K. et al. Homeostatic chemokines and prognosis in patients with acute coronary syndromes. J. Am. Coll. Cardiol. 74, 774\u2013782 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"50125_CR4","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren, F. L. J. et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J. 42, 3227\u20133337 (2021).","journal-title":"Eur. Heart J."},{"key":"50125_CR5","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIRCULATIONAHA.121.057538","volume":"145","author":"JS Lawton","year":"2022","unstructured":"Lawton, J. S. et al. 2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. Circulation 145, e18\u2013e114 (2022).","journal-title":"Circulation"},{"key":"50125_CR6","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1161\/CIRCULATIONAHA.109.912568","volume":"123","author":"TJ Wang","year":"2011","unstructured":"Wang, T. J. Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction. Circulation 123, 551\u2013565 (2011).","journal-title":"Circulation"},{"key":"50125_CR7","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1161\/CIRCULATIONAHA.109.849166","volume":"121","author":"DM Lloyd-Jones","year":"2010","unstructured":"Lloyd-Jones, D. M. Cardiovascular risk prediction: basic concepts, current status, and future directions. Circulation 121, 1768\u20131777 (2010).","journal-title":"Circulation"},{"key":"50125_CR8","doi-asserted-by":"publisher","first-page":"e000403","DOI":"10.1161\/JAHA.113.000403","volume":"3","author":"MW Sherwood","year":"2014","unstructured":"Sherwood, M. W. & Kristin Newby, L. High-sensitivity troponin assays: evidence, indications, and reasonable use. J. Am. Heart Assoc. 3, e000403 (2014).","journal-title":"J. Am. Heart Assoc."},{"key":"50125_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/EC9.0000000000000019","volume":"1","author":"Y Chen","year":"2021","unstructured":"Chen, Y. Expert consensus on the emergency diagnosis and therapy of acute chest pain (English version). Emerg. Crit. Care Med. 1, 53\u201363 (2021).","journal-title":"Emerg. Crit. Care Med."},{"key":"50125_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/CIRCGENETICS.109.852814","volume":"3","author":"SH Shah","year":"2010","unstructured":"Shah, S. H. et al. Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events. Circ. Cardiovasc. Genet. 3, 207\u2013214 (2010).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"50125_CR11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13578-022-00863-x","volume":"12","author":"Q Zhu","year":"2022","unstructured":"Zhu, Q. et al. Plasma metabolomics provides new insights into the relationship between metabolites and outcomes and left ventricular remodeling of coronary artery disease. Cell Biosci. 12, 173 (2022).","journal-title":"Cell Biosci."},{"key":"50125_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.189","volume":"10","author":"M Qin","year":"2020","unstructured":"Qin, M. et al. Insights into the prognosis of lipidomic dysregulation for death risk in patients with coronary artery disease. Clin. Transl. Med. 10, e189 (2020).","journal-title":"Clin. Transl. Med."},{"key":"50125_CR13","doi-asserted-by":"publisher","first-page":"e000032","DOI":"10.1161\/HCG.0000000000000032","volume":"10","author":"S Cheng","year":"2017","unstructured":"Cheng, S. et al. Potential impact and study considerations of metabolomics in cardiovascular health and disease: a scientific statement from the American Heart Association. Circ. Cardiovasc. Genet. 10, e000032 (2017).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"50125_CR14","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrm.2016.25","volume":"17","author":"CH Johnson","year":"2016","unstructured":"Johnson, C. H., Ivanisevic, J. & Siuzdak, G. Metabolomics: beyond biomarkers and towards mechanisms. Nat. Rev. Mol. Cell Biol. 17, 451\u2013459 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"50125_CR15","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2174\/1871529X18666180420170108","volume":"18","author":"VT Dang","year":"2018","unstructured":"Dang, V. T., Huang, A. & Werstuck, G. H. Untargeted metabolomics in the discovery of novel biomarkers and therapeutic targets for atherosclerotic cardiovascular diseases. Cardiovasc. Hematol. Disord. Drug Targets 18, 166\u2013175 (2018).","journal-title":"Cardiovasc. Hematol. Disord. Drug Targets"},{"key":"50125_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrm3314","volume":"13","author":"GJ Patti","year":"2012","unstructured":"Patti, G. J., Yanes, O. & Siuzdak, G. Innovation: metabolomics: the apogee of the omics trilogy. Nat. Rev. Mol. Cell Biol. 13, 263\u2013269 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"50125_CR17","first-page":"100479","volume":"25","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. Biomarker-based risk model to predict cardiovascular events in patients with acute coronary syndromes\u2014results from BIPass registry. Lancet Reg. Health West Pac. 25, 100479 (2022).","journal-title":"Lancet Reg. Health West Pac."},{"key":"50125_CR18","first-page":"200134","volume":"14","author":"SK Storesund","year":"2022","unstructured":"Storesund, S. K. et al. Even chained acylcarnitines predict long-term cardiovascular prognosis in patients with chest pain and non-obstructive coronary artery disease. Int J. Cardiol. Cardiovasc. Risk Prev. 14, 200134 (2022).","journal-title":"Int J. Cardiol. Cardiovasc. Risk Prev."},{"key":"50125_CR19","doi-asserted-by":"publisher","first-page":"e003620","DOI":"10.1161\/JAHA.116.003620","volume":"6","author":"E Strand","year":"2017","unstructured":"Strand, E. et al. Serum acylcarnitines and risk of cardiovascular death and acute myocardial infarction in patients with stable angina pectoris. J. Am. Heart Assoc. 6, e003620 (2017).","journal-title":"J. Am. Heart Assoc."},{"key":"50125_CR20","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1161\/CIRCRESAHA.116.306842","volume":"118","author":"PC Schulze","year":"2016","unstructured":"Schulze, P. C., Drosatos, K. & Goldberg, I. J. Lipid use and misuse by the heart. Circ. Res. 118, 1736\u20131751 (2016).","journal-title":"Circ. Res."},{"key":"50125_CR21","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/EC9.0000000000000024","volume":"2","author":"C Li","year":"2022","unstructured":"Li, C., Liu, H., Xu, F. & Chen, Y. The role of lipotoxicity in cardiovascular disease. Emerg. Crit. Care Med. 2, 214\u2013218 (2022).","journal-title":"Emerg. Crit. Care Med."},{"key":"50125_CR22","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1124\/pharmrev.121.000408","volume":"74","author":"M Dambrova","year":"2022","unstructured":"Dambrova, M. et al. Acylcarnitines: nomenclature, biomarkers, therapeutic potential, drug targets, and clinical trials. Pharm. Rev. 74, 506\u2013551 (2022).","journal-title":"Pharm. Rev."},{"key":"50125_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.mam.2011.10.008","volume":"32","author":"C Indiveri","year":"2011","unstructured":"Indiveri, C. et al. The mitochondrial carnitine\/acylcarnitine carrier: function, structure and physiopathology. Mol. Asp. Med 32, 223\u2013233 (2011).","journal-title":"Mol. Asp. Med"},{"key":"50125_CR24","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.3945\/ajcn.116.130492","volume":"103","author":"M Guasch-Ferre","year":"2016","unstructured":"Guasch-Ferre, M. et al. Plasma acylcarnitines and risk of cardiovascular disease: effect of Mediterranean diet interventions. Am. J. Clin. Nutr. 103, 1408\u20131416 (2016).","journal-title":"Am. J. Clin. Nutr."},{"key":"50125_CR25","doi-asserted-by":"publisher","first-page":"577856","DOI":"10.3389\/fphys.2020.577856","volume":"11","author":"HM Aitken-Buck","year":"2020","unstructured":"Aitken-Buck, H. M., Krause, J., Zeller, T., Jones, P. P. & Lamberts, R. R. Long-chain acylcarnitines and cardiac excitation-contraction coupling: links to arrhythmias. Front. Physiol. 11, 577856 (2020).","journal-title":"Front. Physiol."},{"key":"50125_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17797-x","volume":"7","author":"M Makrecka-Kuka","year":"2017","unstructured":"Makrecka-Kuka, M. et al. Plasma acylcarnitine concentrations reflect the acylcarnitine profile in cardiac tissues. Sci. Rep. 7, 17528 (2017).","journal-title":"Sci. Rep."},{"key":"50125_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2337\/db12-0466","volume":"62","author":"MG Schooneman","year":"2013","unstructured":"Schooneman, M. G., Vaz, F. M., Houten, S. M. & Soeters, M. R. Acylcarnitines: reflecting or inflicting insulin resistance? Diabetes 62, 1\u20138 (2013).","journal-title":"Diabetes"},{"key":"50125_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13668-3","volume":"11","author":"I Martinez-Reyes","year":"2020","unstructured":"Martinez-Reyes, I. & Chandel, N. S. Mitochondrial TCA cycle metabolites control physiology and disease. Nat. Commun. 11, 102 (2020).","journal-title":"Nat. Commun."},{"key":"50125_CR29","doi-asserted-by":"publisher","first-page":"1157325","DOI":"10.3389\/fcvm.2023.1157325","volume":"10","author":"R Sanchez-Gimenez","year":"2023","unstructured":"Sanchez-Gimenez, R. et al. TCA cycle metabolites associated with adverse outcomes after acute coronary syndrome: mediating effect of renal function. Front. Cardiovasc. Med. 10, 1157325 (2023).","journal-title":"Front. Cardiovasc. Med."},{"key":"50125_CR30","doi-asserted-by":"publisher","first-page":"H2122","DOI":"10.1152\/ajpheart.00378.2004","volume":"287","author":"M Benderdour","year":"2004","unstructured":"Benderdour, M. et al. Decreased cardiac mitochondrial NADP+-isocitrate dehydrogenase activity and expression: a marker of oxidative stress in hypertrophy development. Am. J. Physiol. Heart Circ. Physiol. 287, H2122\u2013H2131 (2004).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"50125_CR31","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3390\/healthcare9050603","volume":"9","author":"Y Wang","year":"2021","unstructured":"Wang, Y. & Qian, H. Phthalates and their impacts on human health. Healthcare 9, 603 (2021).","journal-title":"Healthcare"},{"key":"50125_CR32","doi-asserted-by":"publisher","first-page":"106903","DOI":"10.1016\/j.envint.2021.106903","volume":"158","author":"J Eales","year":"2022","unstructured":"Eales, J. et al. Human health impacts of exposure to phthalate plasticizers: an overview of reviews. Environ. Int. 158, 106903 (2022).","journal-title":"Environ. Int."},{"key":"50125_CR33","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1161\/CIRCULATIONAHA.112.001197","volume":"127","author":"F Imamura","year":"2013","unstructured":"Imamura, F. et al. Long-chain monounsaturated Fatty acids and incidence of congestive heart failure in 2 prospective cohorts. Circulation 127, 1512\u20131521 (2013).","journal-title":"Circulation"},{"key":"50125_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.5650\/jos.ess23146","volume":"73","author":"B Duan","year":"2024","unstructured":"Duan, B., Shin, J. A. & Lee, K. T. Quantitative analysis of nervonic and erucic acids in human milk: comparison with infant formula with different fat sources and nutritional stages. J. Oleo Sci. 73, 333\u2013340 (2024).","journal-title":"J. Oleo Sci."},{"key":"50125_CR35","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.ijbiomac.2017.04.051","volume":"105","author":"G Rabbani","year":"2017","unstructured":"Rabbani, G. et al. Binding of erucic acid with human serum albumin using a spectroscopic and molecular docking study. Int J. Biol. Macromol. 105, 1572\u20131580 (2017).","journal-title":"Int J. Biol. Macromol."},{"key":"50125_CR36","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1080\/1028415X.2020.1831262","volume":"25","author":"JBS Kumar","year":"2022","unstructured":"Kumar, J. B. S. & Sharma, B. A review on neuropharmacological role of erucic acid: an omega-9 fatty acid from edible oils. Nutr. Neurosci. 25, 1041\u20131055 (2022).","journal-title":"Nutr. Neurosci."},{"key":"50125_CR37","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.3390\/molecules28041924","volume":"28","author":"A Galanty","year":"2023","unstructured":"Galanty, A., Grudzinska, M., Pazdziora, W. & Pasko, P. Erucic acid-both sides of the story: a concise review on its beneficial and toxic properties. Molecules 28, 1924 (2023).","journal-title":"Molecules"},{"key":"50125_CR38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12944-023-01832-0","volume":"22","author":"J Rong","year":"2023","unstructured":"Rong, J., He, T., Zhang, J., Bai, Z. & Shi, B. Serum lipidomics reveals phosphatidylethanolamine and phosphatidylcholine disorders in patients with myocardial infarction and post-myocardial infarction-heart failure. Lipids Health Dis. 22, 66 (2023).","journal-title":"Lipids Health Dis."},{"key":"50125_CR39","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1161\/CIRCRESAHA.120.317883","volume":"128","author":"C Wittenbecher","year":"2021","unstructured":"Wittenbecher, C. et al. Lipid profiles and heart failure risk: results from two prospective studies. Circ. Res. 128, 309\u2013320 (2021).","journal-title":"Circ. Res."},{"key":"50125_CR40","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1002\/ehf2.12923","volume":"7","author":"C Andersson","year":"2020","unstructured":"Andersson, C. et al. Metabolomic signatures of cardiac remodelling and heart failure risk in the community. ESC Heart Fail 7, 3707\u20133715 (2020).","journal-title":"ESC Heart Fail"},{"key":"50125_CR41","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.jacc.2015.02.018","volume":"65","author":"ML Cheng","year":"2015","unstructured":"Cheng, M. L. et al. Metabolic disturbances identified in plasma are associated with outcomes in patients with heart failure: diagnostic and prognostic value of metabolomics. J. Am. Coll. Cardiol. 65, 1509\u20131520 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"50125_CR42","doi-asserted-by":"publisher","first-page":"e028022","DOI":"10.1161\/JAHA.122.028022","volume":"12","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Metabolomic profiles, ideal cardiovascular health, and risk of heart failure and atrial fibrillation: insights from the Framingham heart study. J. Am. Heart Assoc. 12, e028022 (2023).","journal-title":"J. Am. Heart Assoc."},{"key":"50125_CR43","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3390\/metabo11090621","volume":"11","author":"P McGranaghan","year":"2021","unstructured":"McGranaghan, P. et al. Lipid metabolite biomarkers in cardiovascular disease: discovery and biomechanism translation from human studies. Metabolites 11, 621 (2021).","journal-title":"Metabolites"},{"key":"50125_CR44","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.cct.2012.01.001","volume":"33","author":"F D\u2019Ascenzo","year":"2012","unstructured":"D\u2019Ascenzo, F. et al. TIMI, GRACE and alternative risk scores in acute coronary syndromes: a meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients. Contemp. Clin. Trials 33, 507\u2013514 (2012).","journal-title":"Contemp. Clin. Trials"},{"key":"50125_CR45","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1007\/s13361-016-1469-y","volume":"27","author":"AC Schrimpe-Rutledge","year":"2016","unstructured":"Schrimpe-Rutledge, A. C., Codreanu, S. G., Sherrod, S. D. & McLean, J. A. Untargeted metabolomics strategies-challenges and emerging directions. J. Am. Soc. Mass Spectrom. 27, 1897\u20131905 (2016).","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"50125_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09550-x","volume":"10","author":"X Shen","year":"2019","unstructured":"Shen, X. et al. Metabolic reaction network-based recursive metabolite annotation for untargeted metabolomics. Nat. Commun. 10, 1516 (2019).","journal-title":"Nat. Commun."},{"key":"50125_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34537-6","volume":"13","author":"Z Zhou","year":"2022","unstructured":"Zhou, Z. et al. Metabolite annotation from knowns to unknowns through knowledge-guided multi-layer metabolic networking. Nat. Commun. 13, 6656 (2022).","journal-title":"Nat. Commun."},{"key":"50125_CR48","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","volume":"41","author":"F Faul","year":"2009","unstructured":"Faul, F., Erdfelder, E., Buchner, A. & Lang, A. G. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav. Res. Methods 41, 1149\u20131160 (2009).","journal-title":"Behav. Res. Methods"},{"key":"50125_CR49","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10654-011-9567-4","volume":"26","author":"S Kundu","year":"2011","unstructured":"Kundu, S., Aulchenko, Y. S., van Duijn, C. M. & Janssens, A. C. PredictABEL: an R package for the assessment of risk prediction models. Eur. J. Epidemiol. 26, 261\u2013264 (2011).","journal-title":"Eur. J. Epidemiol."},{"key":"50125_CR50","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/(SICI)1097-0258(19970515)16:9<965::AID-SIM509>3.0.CO;2-O","volume":"16","author":"DW Hosmer","year":"1997","unstructured":"Hosmer, D. W., Hosmer, T., Le Cessie, S. & Lemeshow, S. A comparison of goodness-of-fit tests for the logistic regression model. Stat. Med. 16, 965\u2013980 (1997).","journal-title":"Stat. Med."},{"key":"50125_CR51","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nmeth0410-247","volume":"7","author":"MH Maathuis","year":"2010","unstructured":"Maathuis, M. H., Colombo, D., Kalisch, M. & Buhlmann, P. Predicting causal effects in large-scale systems from observational data. Nat. Methods 7, 247\u2013248 (2010).","journal-title":"Nat. Methods"},{"key":"50125_CR52","doi-asserted-by":"publisher","first-page":"W388","DOI":"10.1093\/nar\/gkab382","volume":"49","author":"Z Pang","year":"2021","unstructured":"Pang, Z. et al. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res. 49, W388\u2013W396 (2021).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50125-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50125-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50125-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T20:22:28Z","timestamp":1720470148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50125-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,8]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["50125"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-50125-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,8]]},"assertion":[{"value":"25 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5729"}}